Longevity doctors warn GLP-1 drugs may cost patients muscle, not just fat. ShapeScale’s 3D scans reveal the loss—and help ...

Like many GLP-1 medications approved for diabetes, however, weight loss is a side effect of Rybelsus. “Data has shown modest ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.

Bernstein reiterated its Outperform rating on Novo Nordisk, saying the company’s diabetes and obesity GLP-1 portfolio remains well-positioned following fresh data from the European Association for the ...

Weight-loss drugs like Ozempic and Mounjaro are currently available in the form of injectables. If Eli Lilly's new trials are ...

The arrival of GLP-1 receptor agonists and dual agonists has delivered unprecedented efficacy, reframed obesity as a chronic ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

While health care is the most obvious place to look for investment opportunities related to GLP-1 trends, we believe some of ...

The 43-year-old retired tennis champ showcased her substantial weight loss in a animal-print teddy over black leggings, ...

During a session on the rise of GLP-1 medications, leading medical experts unpacked the complexities of obesity in India. Dr. Muffazal Lakdawala called these medications as surgery in a pill.

New research from the Cleveland Clinic may explain why some people experience significant weight loss with GLP-1 medications.

Medicare Part D coverage of glucagon-like peptide-1 receptor agonists— widely prescribed for diabetes and increasingly sought for obesity and related conditions— has remained broad. A research letter ...